Dr. Frank R. Vleugels, MD

Dr. Vleugels practices at Martha's Vineyard Hospital in Oak Bluffs, Massachusetts, part of Mass General Brigham.

Dr. Vleugels' NPI, 1922373018, was assigned on March 21, 2012. Dr. Vleugels graduated from University of Cincinnati College of Medicine in 2012. Dr. Vleugels holds Massachusetts license 268672.

Dr. Vleugels' primary practice is Martha's Vineyard Hospital, at One Hospital Road, First Fl, Wing 5, PO Box 1477, Oak Bluffs, MA 02557 in Dukes County. The practice phone is (508) 693-0410. Dr. Vleugels also practices at Martha's Vineyard Hospital, 1 Hospital Way, Oak Bluffs, MA 02557.

Dr. Vleugels' primary practice is Martha's Vineyard Hospital in Oak Bluffs, Massachusetts, part of Mass General Brigham. Dr. Vleugels is also affiliated with Massachusetts General Hospital. The medical group on file is Martha's Vineyard Hospital. Dmand AI also links Dr. Vleugels to 3 more medical groups, 1 group practice or clinic and 1 senior living community, each named with a free account. Dr. Vleugels' employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vleugels practices, 4 sites in all. Vendor and product names are available with a free account.

Procedural dermatology is Dr. Vleugels' primary specialty in the NPI Registry, under taxonomy code 207NS0135X. Dr. Vleugels is licensed in Massachusetts.

CMS data shows 616 Medicare services from Dr. Vleugels across 6 procedure codes in 2024, for 188 Medicare patients. Medicare paid $24,026 for them. Every service was in an office.

CMS counts 188 Medicare patients who saw Dr. Vleugels in 2024. The largest group is 65 to 74, with 85 patients. 75% of them have high cholesterol, and 70% have high blood pressure. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Vleugels' median patient age at 76, with 51% women.

In 2024, Dr. Vleugels wrote 597 Medicare Part D claims for 281 patients. 96% of them were for generic drugs. CMS names the drug for 499 of them, across 11 drugs with 11 or more claims each, at $14,180 in total drug cost. In 2023, CMS named 554 claims across 16 drugs.

Dr. Vleugels accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of removal of skin lesions by Dr. Vleugels, more than 60% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Vleugels, published from 2012 to 2025. 2012 was the busiest year, with 2. Dr. Vleugels has published most often in JAAD Case Rep. Dr. Vleugels' most frequent co-authors are Christine Michelle Cornejo, Sasha Danielle Girouard, MD and Wei-Che C. Ko, MD.

CMS Open Payments shows 12 general payments to Dr. Vleugels from 7 drug and device companies from 2016 to 2023. Speaker and faculty fees make up the largest share, 60% of the total. Teladoc Health, Inc. paid the most, $1,425.

Dr. Vleugels graduated from University of Cincinnati College of Medicine in 2012.